Foresite Capital Management IV’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-875,000
| Closed | -$16.8M | – | 5 |
|
|
2024
Q3 | $16.8M | Hold |
875,000
| – | – | 11.01% | 3 |
|
|
2024
Q2 | $18M | Hold |
875,000
| – | – | 12.07% | 3 |
|
|
2024
Q1 | $20.8M | Hold |
875,000
| – | – | 10.52% | 4 |
|
|
2023
Q4 | $18.9M | Hold |
875,000
| – | – | 9.56% | 4 |
|
|
2023
Q3 | $12.7M | Hold |
875,000
| – | – | 7.06% | 7 |
|
|
2023
Q2 | $18.3M | Hold |
875,000
| – | – | 9% | 7 |
|
|
2023
Q1 | $18.5M | Hold |
875,000
| – | – | 9.59% | 6 |
|
|
2022
Q4 | $22.3M | Buy |
875,000
+185,000
| +27% | +$4.71M | 9.51% | 6 |
|
|
2022
Q3 | $16.6M | Buy |
+690,000
| New | +$16.6M | 5.33% | 6 |
|